Novo Nordisk expects drugs excluded from sanctions against Russia

Danish pharmaceutical firm Novo Nordisk is concerned for its employees in Ukraine as Russian forces invade the country from multiple fronts (Corrected)

Photo: Novo Nordisk / PR

(Corrected at 16.29 - It was stated earlier in the article that Novo Nordisk has not closed its office in the capital Kiev. This is not correct. As of Thursday the office is closed, the pharmaceutical company informs MedWatch. MedWatch apologizes for the error.)

Russia’s ongoing invasion of Ukraine is cause for concern for Novo Nordisk, which has around 100 employees working in the country.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs